AI Buyer Insights:

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

Cantor Fitzgerald, a Kyriba Treasury customer evaluated GTreasury

Michelin, an e2open customer evaluated Oracle Transportation Management

Citigroup, a VestmarkONE customer evaluated BlackRock Aladdin Wealth

Swedbank, a Temenos T24 customer evaluated Oracle Flexcube

Wayfair, a Korber HighJump WMS customer just evaluated Manhattan WMS

Moog, an UKG AutoTime customer evaluated Workday Time and Attendance

Westpac NZ, an Infosys Finacle customer evaluated nCino Bank OS

List of Revvity Research & Development Customers

Apply Filters For Customers

Logo Customer Industry Empl. Revenue Country Vendor Application Category When SI Insight
Camurus Life Sciences 250 $66M Sweden Revvity Revvity Research & Development Clinical Trial Management 2023 n/a
Eli Lilly Life Sciences 50605 $65.2B United States Revvity Revvity Research & Development Clinical Trial Management 2025 n/a
Merck Group Life Sciences 59020 $23.3B Germany Revvity Revvity Research & Development Clinical Trial Management 2024 n/a
Showing 1 to 3 of 3 entries

Buyer Intent: Companies Evaluating Revvity Research & Development

ARTW Buyer Intent uncovers actionable customer signals, identifying software buyers actively evaluating Revvity Research & Development. Gain ongoing access to real-time prospects and uncover hidden opportunities.

Discover Software Buyers actively Evaluating Enterprise Applications

Logo Company Industry Employees Revenue Country Evaluated
No data found
FAQ - APPS RUN THE WORLD Revvity Research & Development Coverage

Revvity Research & Development is a Clinical Trial Management solution from Revvity.

Companies worldwide use Revvity Research & Development, from small firms to large enterprises across 21+ industries.

Organizations such as Eli Lilly, Merck Group and Camurus are recorded users of Revvity Research & Development for Clinical Trial Management.

Companies using Revvity Research & Development are most concentrated in Life Sciences, with adoption spanning over 21 industries.

Companies using Revvity Research & Development are most concentrated in United States, Germany and Sweden, with adoption tracked across 195 countries worldwide. This global distribution highlights the popularity of Revvity Research & Development across Americas, EMEA, and APAC.

Companies using Revvity Research & Development range from small businesses with 0-100 employees - 0%, to mid-sized firms with 101-1,000 employees - 33.33%, large organizations with 1,001-10,000 employees - 0%, and global enterprises with 10,000+ employees - 66.67%.

Customers of Revvity Research & Development include firms across all revenue levels — from $0-100M, to $101M-$1B, $1B-$10B, and $10B+ global corporations.

Contact APPS RUN THE WORLD to access the full verified Revvity Research & Development customer database with detailed Firmographics such as industry, geography, revenue, and employee breakdowns as well as key decision makers in charge of Clinical Trial Management.